Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases
Cristina Prandi, Marco Blangetti, Dvora Namdar, et al.
Molecules (2018) Vol. 23, Iss. 7, pp. 1526-1526
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment
Anna Stasiłowicz-Krzemień, Anna Tomala, Irma Podolak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 778-778
Open Access | Times Cited: 76
The Origin and Biomedical Relevance of Cannabigerol
Anna Jastrząb, Iwona Jarocka-Karpowicz, Elżbieta Skrzydlewska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7929-7929
Open Access | Times Cited: 57
Cannabidiol-Based Thiosemicarbazones: A Preliminary Study Evaluating Their Anti-Tyrosinase Properties
E Peretz, Nissan Ashkenazi, Sanaa Musa
Molecules (2025) Vol. 30, Iss. 6, pp. 1291-1291
Open Access | Times Cited: 1
Phytocannabinoids in the Pharmacotherapy of Psoriasis
Adam Wroński, Iwona Jarocka-Karpowicz, Anna Stasiewicz, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1192-1192
Open Access | Times Cited: 19
Structural and Functional Insights into Cannabinoid Receptors
Xiaoting Li, Ling Shen, Tian Hua, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 9, pp. 665-677
Closed Access | Times Cited: 50
The Biochemistry of Phytocannabinoids and Metabolic Engineering of Their Production in Heterologous Systems
Kaitlyn Blatt-Janmaat, Yang Qu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2454-2454
Open Access | Times Cited: 35
Natural product-based pharmacological studies for neurological disorders
Vivek Puri, Neha Kanojia, Ameya Sharma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Biosynthesis of Phytocannabinoids and Structural Insights: A Review
Rasiravathanahalli Kaveriyappan Govindarajan, Awdhesh Kumar Mishra, Kiu-Hyung Cho, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 442-442
Open Access | Times Cited: 16
Using In Silico Molecular Docking to Explain Differences in Receptor Binding Behavior of HHC and THCV Isomers: Revealing New Binding Modes
Mehdi Haghdoost, Yossef López de los Santos, Megan Brunstetter, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 637-637
Open Access | Times Cited: 5
CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design
Aditi Das, Austin T. Weigle, William R. Arnold, et al.
Pharmacology & Therapeutics (2020) Vol. 215, pp. 107601-107601
Open Access | Times Cited: 39
Attenuation of Oxidative Stress by Cannabinoids and Cannabis Extracts in Differentiated Neuronal Cells
Aruna Raja, Soha Ahmadi, Fernanda de Costa, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 11, pp. 328-328
Open Access | Times Cited: 39
Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions
Joshua D. Brown, Kevin J. Rivera Rivera, Leilanie Y. Crespo Hernandez, et al.
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 30
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7686-7686
Open Access | Times Cited: 12
Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways
Banashree Chetia Phukan, Rubina Roy, Indira Gahatraj, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5657-5699
Open Access | Times Cited: 11
Topical Use of Cannabis sativa L. Biochemicals
Léonid Mnekin, Lionel Ripoll
Cosmetics (2021) Vol. 8, Iss. 3, pp. 85-85
Open Access | Times Cited: 26
Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
Md Sultan Mahmud, Mohammad Sorowar Hossain, A T M Faiz Ahmed, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7216-7216
Open Access | Times Cited: 26
Structural basis of THC analog activity at the Cannabinoid 1 receptor
Thor S. Thorsen, Yashraj Kulkarni, David A. Sykes, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
An overview of neural networks for drug discovery and the inputs used
Yinqiu Xu, Hequan Yao, Kejiang Lin
Expert Opinion on Drug Discovery (2018) Vol. 13, Iss. 12, pp. 1091-1102
Closed Access | Times Cited: 32
Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview
Iqra Kalsoom, Kiran Shehzadi, Hansheng Li, et al.
Topics in Current Chemistry (2024) Vol. 382, Iss. 2
Closed Access | Times Cited: 3
Cannabinoid receptor 2 (CB2) modulators: A patent review (2016–2024)
Rayees Ahmad Naikoo, Ritu Painuli, Zaheen Akhter, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107775-107775
Closed Access | Times Cited: 3
Cannabinoids—Multifunctional Compounds, Applications and Challenges—Mini Review
Dominik Duczmal, Aleksandra Bazan-Woźniak, Krystyna Niedzielska, et al.
Molecules (2024) Vol. 29, Iss. 20, pp. 4923-4923
Open Access | Times Cited: 3
The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β‐evoked neurotoxicity and changes in cell morphology in PC12 cells
Dylan T. Marsh, Ayato Sugiyama, Yuta Imai, et al.
Basic & Clinical Pharmacology & Toxicology (2023) Vol. 134, Iss. 3, pp. 293-309
Open Access | Times Cited: 8
Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC
Rachel D. Hutchison, Benjamin M. Ford, Lirit N. Franks, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 21
Discovery of Latent Cannabichromene Cyclase Activity in Marine Bacterial Flavoenzymes
Anna Love, Trevor N. Purdy, Felix M. Hubert, et al.
ACS Synthetic Biology (2024) Vol. 13, Iss. 4, pp. 1343-1354
Open Access | Times Cited: 2
Cannabinoid Effects on Experimental Colorectal Cancer Models Reduce Aberrant Crypt Foci (ACF) and Tumor Volume: A Systematic Review
Eduardo Orrego-González, Luisa Londoño-Tobón, José Luis Ardila-González, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top